CS logo
small CS logo
Klinikum Esslingen

Esslingen, Germany
General hospital in Esslingen am Neckar, Baden-Württemberg
Hirschlandstraße 97, 73730 Esslingen am Neckar

About Klinikum Esslingen


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
University of Ulm
8
Boehringer Ingelheim
6
AIO-Studien-gGmbH
4
Abbott Medical Devices
4
German CLL Study Group
4
Celgene
2
Daiichi Sankyo, Inc.
2
Hoffmann-La Roche
2
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
2
Stichting Hemato-Oncologie voor Volwassenen Nederland
2
AGO Research GmbH
1
Total Rows: 37

Clinical Trials at Klinikum Esslingen


During the past decade, Klinikum Esslingen conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 8 clinical trials were completed, i.e. on average, 27.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 5 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33115533668800330000111111332200Started TrialsCompleted Trails201520162017201820192020202120220246810
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fludarabine or Observation in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
1997-04-01
2010-06-01
Completed
877
Alemtuzumab in Treating Patients With Advanced Chronic Lymphocytic Leukemia That Did Not Respond to Previous Fludarabine
2002-09-01
2009-08-01
Completed
Bendamustine and Rituximab in Treating Patients With Previously Untreated or Relapsed Chronic Lymphocytic Leukemia
2005-11-01
2011-03-01
Completed
195
Fludarabine With or Without Cyclophosphamide in Treating Patients With Advanced Chronic Lymphocytic Leukemia
1999-07-01
2007-07-01
Completed
375
Fludarabine and Cyclophosphamide With or Without Rituximab in Patients With Previously Untreated Chronic B-Cell Lymphocytic Leukemia
2003-07-01
2011-10-01
Completed
817
Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma
2004-02-01
2015-11-01
Completed
586
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
2006-04-01
Completed
1,520
Trial of Docetaxel, Oxaliplatin and Capecitabine (TEX) in Advanced or Metastatic Gastric Cancer
2007-08-01
2013-01-01
Completed
56

Rows per page:

1–63 of 63

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Klinikum Esslingen" #1 sponsor was "University of Ulm" with 8 trials, followed by "Boehringer Ingelheim" with 6 trials sponsored, "AIO-Studien-gGmbH" with 4 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "German CLL Study Group" with 4 trials sponsored. Other sponsors include 32 different institutions and companies that sponsored additional 37 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Esslingen" #1 collaborator was "German Breast Group" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "ClinAssess GmbH" with 2 trials as a collaborator. Other collaborators include 39 different institutions and companies that were collaborators in the rest 48 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUniversity of Ulm: 8University of Ulm: 8Boehringer Ingelheim: 6Boehringer Ingelheim: 6AIO-Studien-gGmbH: 4AIO-Studien-gGmbH: 4Abbott Medical Devices: 4Abbott Medical Devices: 4German CLL Study Group: 4German CLL Study Group: 4Celgene: 2Celgene: 2Daiichi Sankyo, Inc.: 2Daiichi Sankyo, Inc.: 2Hoffmann-La Roche: 2Hoffmann-La Roche: 2Institut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 2Institut für KlinischeKrebsforschung IKFGmbH at KrankenhausNordwest: 2Stichting Hemato-Oncologie voorVolwassenenNederland: 2Stichting Hemato-Oncologie voorVolwassenenNederland: 2

Created with Highcharts 11.1.0Top CollaboratorsGerman Breast Group: 4German Breast Group: 4ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 2ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 2AstraZeneca: 2AstraZeneca: 2Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2ClinAssess GmbH: 2ClinAssess GmbH: 2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2Deutsch-ÖsterreichischeStudiengruppe AkuteMyeloische Leukämie(AMLSG): 2AGO-B: 1AGO-B: 1ARCAGY/ GINECO GROUP: 1ARCAGY/ GINECO GROUP: 1AWOgyn: 1AWOgyn: 1Amgen: 1Amgen: 1

Clinical Trials Conditions at Klinikum Esslingen


According to Clinical.Site data, the most researched conditions in "Klinikum Esslingen" are "Carcinoma, Non-Small-Cell Lung" (6 trials), "Acute Myeloid Leukemia" (5 trials), "Acute Myeloid Leukemia (AML)" (5 trials), "Breast Cancer" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Klinikum Esslingen" in a lesser frequency.

Clinical Trials Intervention Types at Klinikum Esslingen


Most popular intervention types in "Klinikum Esslingen" are "Drug" (47 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (5 trials) and "Procedure" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Cytarabine" (5 trials), "Gemcitabine" (5 trials), "Carboplatin" (4 trials) and "Atezolizumab" (3 trials). Other intervention names were less common.

Clinical Trials Genders at Klinikum Esslingen


The vast majority of trials in "Klinikum Esslingen" are 57 trials for "All" genders and 6 trials for "Female" genders.

Clinical Trials Status at Klinikum Esslingen


Currently, there are NaN active trials in "Klinikum Esslingen". undefined are not yet recruiting, 15 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Klinikum Esslingen, undefined suspended trials, and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Esslingen, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 24Phase 2: 24Phase 3: 24Phase 3: 24Not Applicable: 4Not Applicable: 4Phase 1: 2Phase 1: 2

Created with Highcharts 11.1.0Trials StatusCompleted: 31Completed: 31Recruiting: 15Recruiting: 15Active, not recruiting: 9Active, not recruiting: 9Terminated: 4Terminated: 4Unknown status: 4Unknown status: 4

Departments of Klinikum Esslingen


Klinikum Esslingen has several departments that took part in Clinical trials: "Klinikum Esslingen; Klinik für Kardiologie, Angiologie und Pneumologie" - 5 trials, "Klinikum Esslingen Klinik für Onkologie, Gastroenterologie und Allgemeine Innere Medizin" - 4 trials